UK-based Monica Healthcare, one of the earliest digital health companies, has been acquired by GE Healthcare.
While the terms of the deal were not disclosed, investor Catapult Ventures shared that it recieved a 3.5x return on its investment. MobiHealthNews’s reporting has the company’s total funding to date around $7 million.
“At GE Healthcare, we are committed to improving the health care experience across care areas, including childbirth,” Tammy Noll, general manager of GE Healthcare’s Maternal-Infant Care division, said in a statement. “Through this acquisition, we will combine the incredible expertise and mobile-digital innovation from the Monica team with GE Healthcare’s longstanding industry leadership and customer focus – all with the goal of bettering maternal and infant care for patients worldwide.”
Monica makes a Bluetooth-connected fetal monitor called the Novii Wireless Patch System. The single-use patch monitors maternal heart rate, fetal heart rate, and uterine activity. It was FDA cleared in 2014 and builds on an older technology called the AN24 system that was cleared in 2011. The technology performs especially well on pregnant people who are obese, a situation where traditional doppler ultrasounds are less reliable.
Founded in 2005, Monica Healthcare was one of the early players in the digital health space. GE Healthcare’s relationship with the company isn’t totally new: it has been a distribution partner since 2015. According to Catapult Ventures, Monica’s technologies were used by more than 100,000 patients last year at approximately 1,000 sites across Europe, Asia and North America.
“Joining GE Healthcare provides a fantastic opportunity to bring together Monica’s digital offerings with GE Healthcare’s global infrastructure to provide even stronger capabilities and solutions to customers around the world,” Carl Barratt, CEO of Monica Healthcare, said in a statement.
By Jonah Comstock
Source: MobiHealthNews
Giovanni Caforio, the former CEO of Bristol Myers Squibb, is set to become the next board chairman of Novartis, which on Tuesday proposed the pharmaceutical industry veteran as its pick to replace Joerg Reinhardt in the role next year. Reinhardt has served as Novartis’ chair since 2013 and plans to retire when his 12-year term ends in 2025.
GE HealthCare has raised the curtain on two ultrasound systems equipped with artificial intelligence programs designed to assist in diagnosing conditions in women’s health, including obstetric exams. The Voluson Signature 20 and 18 imaging systems include AI tools capable of automatically identifying and annotating measurements of fetal anatomy.
Scientists from the University of Edinburgh’s School of Chemistry have revealed a new sustainable method of manufacturing complex molecules that could reduce waste produced during drug production. The method published in Nature Chemistry could help to prevent severe side effects caused by drugs that can exist as enantiomers.
